GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.19; Lowers FY14 EPS Growth Outlook
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of GBP0.19, versus GBP0.26 reported last year. Revenue for the quarter came in at GBP5.56 billion, versus GBP6.62 billion reported last year.
Full year 2014 core EPS now expected to be broadly similar to 2013, from prior growth expectations of 4 to 8 percent.
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Farmers National Banc (FMNB) Tops Q1 EPS by 1c
- Canadian Pacific Kansas City (CP) Tops Q1 EPS by 93c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!